ATE296606T1 - Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon - Google Patents

Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon

Info

Publication number
ATE296606T1
ATE296606T1 AT04737220T AT04737220T ATE296606T1 AT E296606 T1 ATE296606 T1 AT E296606T1 AT 04737220 T AT04737220 T AT 04737220T AT 04737220 T AT04737220 T AT 04737220T AT E296606 T1 ATE296606 T1 AT E296606T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
form containing
rapid release
polymorphous tibolone
tibolone
Prior art date
Application number
AT04737220T
Other languages
English (en)
Inventor
Haan Pieter N V Organon De
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33442854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE296606(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE296606T1 publication Critical patent/ATE296606T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04737220T 2003-05-23 2004-05-19 Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon ATE296606T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101500 2003-05-23
PCT/EP2004/050852 WO2004103378A1 (en) 2003-05-23 2004-05-19 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Publications (1)

Publication Number Publication Date
ATE296606T1 true ATE296606T1 (de) 2005-06-15

Family

ID=33442854

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04737220T ATE296606T1 (de) 2003-05-23 2004-05-19 Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon

Country Status (16)

Country Link
US (1) US20060134191A1 (de)
EP (1) EP1499278B1 (de)
JP (1) JP2006514996A (de)
KR (2) KR20050038590A (de)
AT (1) ATE296606T1 (de)
AU (1) AU2004203420B8 (de)
CA (1) CA2473718A1 (de)
DE (1) DE602004000016T2 (de)
DK (1) DK1499278T3 (de)
ES (1) ES2243919T3 (de)
MX (1) MXPA05000824A (de)
NZ (1) NZ534446A (de)
PL (1) PL1499278T3 (de)
PT (1) PT1499278E (de)
WO (1) WO2004103378A1 (de)
ZA (1) ZA200406042B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274386T3 (es) * 2004-02-06 2007-05-16 Helm Ag Preparaciones farmaceuticas que contienen tibolona amorfa.
JP5350388B2 (ja) * 2007-10-25 2013-11-27 ノバルティス アーゲー 単位用量薬物パッケージの粉体調整
KR101361244B1 (ko) * 2012-02-23 2014-02-11 박현석 무선 메시지를 이용한 문서 전송 시스템 및 방법
US10139090B2 (en) * 2015-11-02 2018-11-27 Joseph Goodrich Rechargeable illuminating shoes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (de) * 1964-06-16
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
WO2001054699A1 (en) * 2000-01-28 2001-08-02 Endorecherche, Inc. Selective estrogen receptor modulators in combination with estrogens
EP1444247B1 (de) * 2001-10-18 2007-06-13 Norton Healthcare Limited Tibolonformulierungen

Also Published As

Publication number Publication date
PT1499278E (pt) 2005-08-31
NZ534446A (en) 2007-03-30
AU2004203420B2 (en) 2008-01-31
US20060134191A1 (en) 2006-06-22
DK1499278T3 (da) 2005-10-03
JP2006514996A (ja) 2006-05-18
EP1499278A1 (de) 2005-01-26
DE602004000016D1 (de) 2005-07-07
CA2473718A1 (en) 2004-11-23
KR20050038590A (ko) 2005-04-27
EP1499278B1 (de) 2005-06-01
PL1499278T3 (pl) 2005-09-30
DE602004000016T2 (de) 2005-11-03
ZA200406042B (en) 2006-05-31
KR20060028822A (ko) 2006-04-03
MXPA05000824A (es) 2005-04-28
ES2243919T3 (es) 2005-12-01
AU2004203420A1 (en) 2004-12-02
AU2004203420B8 (en) 2008-02-21
WO2004103378A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
DK0954314T3 (da) Doseringsformer til bedring af mandlig erektionsdefekt
ME00482B (me) Čvrste farmaceutske kompozicije koje sadrže pregabalin sredstvo za formiranje matriksa i sredstvo za bubrenje
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
CY1105170T1 (el) Συνταγοποιηση απο του στοματος δοσολογιας αστραπιαιας - τηξης
ATE396712T1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
MX2008012731A (es) Tabletas de paracetamol de liberacion rapida.
NO20060445L (no) Fast farmasoytisk preparat omfattende amisulprid
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
ZA200506992B (en) Fibrate tablet and method for the production thereof
ES2189739T3 (es) Composiciones de betahistina de liberacion controlada.
ATE296606T1 (de) Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
TR200601092T1 (tr) İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar.
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
MY141008A (en) Oral formulations of deoxypeganine and their uses
DE60211916D1 (de) Synergistische füllzusammensetzung
BR0311209A (pt) Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete
IL162769A0 (en) Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen
WO2005115092A3 (en) Micronized oral pharmaceutical composition
ECSP003607A (es) Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1499278

Country of ref document: EP

RRZN Revocation of revocation